| CTRI Number |
CTRI/2025/10/096730 [Registered on: 31/10/2025] Trial Registered Prospectively |
| Last Modified On: |
30/10/2025 |
| Post Graduate Thesis |
Yes |
| Type of Trial |
Interventional |
|
Type of Study
|
Medical Device |
| Study Design |
Single Arm Study |
|
Public Title of Study
|
Magnetic brain stimulation as an additional treatment for children and teenagers with obsessive-compulsive disorder |
|
Scientific Title of Study
|
Deep Transcranial Magnetic Stimulation as add-on treatment for Children and Adolescents with Obsessive Compulsive Disorder: An open label study |
| Trial Acronym |
NIL |
|
Secondary IDs if Any
|
| Secondary ID |
Identifier |
| NIL |
NIL |
|
|
Details of Principal Investigator or overall Trial Coordinator (multi-center study)
|
| Name |
Dr Priyadeep Zamindar |
| Designation |
Senior Resident |
| Affiliation |
NIMHANS, Bengaluru |
| Address |
Department of Child and Adolescent Psychiatry, NIMHANS, Hosur Road, Bengaluru, India, 560029
Bangalore KARNATAKA 560029 India |
| Phone |
9830991303 |
| Fax |
|
| Email |
zamindard@gmail.com |
|
Details of Contact Person Scientific Query
|
| Name |
Dr Harshini Manohar |
| Designation |
Assistant Professor |
| Affiliation |
NIMHANS, Bengaluru |
| Address |
2nd floor, Adolescent psychiatry building, Department of Child and Adolescent Psychiatry, NIMHANS, Hosur Road, Bengaluru, India, 560029
Bangalore KARNATAKA 560029 India |
| Phone |
9176402954 |
| Fax |
|
| Email |
harshinimanohar1990@gmail.com |
|
Details of Contact Person Public Query
|
| Name |
Dr Harshini Manohar |
| Designation |
Assistant Professor |
| Affiliation |
NIMHANS, Bengaluru |
| Address |
2nd floor, Adolescent psychiatry building, Department of Child and Adolescent Psychiatry, NIMHANS, Hosur Road, Bengaluru, India, 560029
Bangalore KARNATAKA 560029 India |
| Phone |
9176402954 |
| Fax |
|
| Email |
harshinimanohar1990@gmail.com |
|
|
Source of Monetary or Material Support
|
| National Institute of Mental Health And Neurosciences, Hosur Road, Bengaluru, India, 560029 |
|
|
Primary Sponsor
|
| Name |
NIMHANS Bengaluru |
| Address |
NIMHANS, Hosur Road, Bengaluru, India, 560029 |
| Type of Sponsor |
Research institution and hospital |
|
|
Details of Secondary Sponsor
|
|
|
Countries of Recruitment
|
India |
|
Sites of Study
|
| No of Sites = 1 |
| Name of Principal
Investigator |
Name of Site |
Site Address |
Phone/Fax/Email |
| Dr Priyadeep Zamindar |
NIMHANS Hospital |
Department of Child and Adolescent Psychiatry, NIMHANS, Hosur Road, Bengaluru, India, 560029 Bangalore KARNATAKA |
9830991303
zamindard@gmail.com |
|
|
Details of Ethics Committee
|
| No of Ethics Committees= 1 |
| Name of Committee |
Approval Status |
| NIMHANS ETHICS COMMITTEE |
Approved |
|
|
Regulatory Clearance Status from DCGI
|
|
|
Health Condition / Problems Studied
|
| Health Type |
Condition |
| Patients |
(1) ICD-10 Condition: F422||Mixed obsessional thoughts and acts, |
|
|
Intervention / Comparator Agent
|
| Type |
Name |
Details |
| Intervention |
Deep Transcranial Magnetic Stimulation |
Deep Transcranial Magnetic Stimulation (dTMS) is a non-invasive brain stimulation modality that uses repeated pulses of magnetic stimulation in specific parts of the brain. The current study involves use of the H7 dTMS coils to target the Anterior Cingulate Cortex (ACC) and medial Pre-frontal Cortex (mPFC) using "High Frequency" 20Hz stimulation in standardized protocol for OCD.
Each session will take roughly 20 minutes each. Each participant will be given 20 sessions total at one session per day, 6 days a week. |
| Comparator Agent |
Not Applicable |
Not Applicable |
|
|
Inclusion Criteria
|
| Age From |
7.00 Year(s) |
| Age To |
17.00 Year(s) |
| Gender |
Both |
| Details |
Individuals with primary diagnosis of OCD as per DSM-5, age 7-17 of any gender, with a previous trail of at least 12 weeks of an SSRI or CBT |
|
| ExclusionCriteria |
| Details |
History of seizure, head injury, other neurological conditions that may reduce seizure threshold, raised intra-cranial tension, metal implants in head or face, Severe metal illness such as Schizophrenia or Bipolar Disorder, Acute suicidal Risk, Moderate/Severe/Profound Intellectual Disability |
|
|
Method of Generating Random Sequence
|
Not Applicable |
|
Method of Concealment
|
Not Applicable |
|
Blinding/Masking
|
Not Applicable |
|
Primary Outcome
|
| Outcome |
TimePoints |
Reduction in the severity of obsessive-compulsive symptoms as assessed by CY-BOCS, post intervention
Overall clinical improvement as assessed by CGI, post intervention |
Baseline, 4 weeks, 1 month post-intervention and 3 months post-intervention |
|
|
Secondary Outcome
|
| Outcome |
TimePoints |
| Reduction in comorbid depression and anxiety symptoms post intervention as assessed by RCADS |
T1- Pre-intervention
T2- Post 20 sessions of dTMS |
| Maintenance of intervention effects at 1 month (T3) and 3 months (T4) post-intervention as measured by CY-BOCS and CGI scores |
T1- Pre-intervention
T2- Post 20 sessions of dTMS
T3- 1 month post-intervention
T4- 3 months post-intervention |
|
|
Target Sample Size
|
Total Sample Size="20" Sample Size from India="20"
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" |
|
Phase of Trial
|
N/A |
|
Date of First Enrollment (India)
|
18/11/2025 |
| Date of Study Completion (India) |
Applicable only for Completed/Terminated trials |
| Date of First Enrollment (Global) |
Date Missing |
| Date of Study Completion (Global) |
Applicable only for Completed/Terminated trials |
|
Estimated Duration of Trial
|
Years="1" Months="0" Days="0" |
|
Recruitment Status of Trial (Global)
|
Not Yet Recruiting |
| Recruitment Status of Trial (India) |
Not Yet Recruiting |
|
Publication Details
|
N/A |
|
Individual Participant Data (IPD) Sharing Statement
|
Will individual participant data (IPD) be shared publicly (including data dictionaries)?
Response - YES
- What data in particular will be shared?
Response - Individual participant data that underlie the results reported in this article, after de-identification (text, tables, figures, and appendices).
- What additional supporting information will be shared?
Response - Study Protocol Response - Statistical Analysis Plan Response - Informed Consent Form Response - Clinical Study Report Response - Analytic Code
- Who will be able to view these files?
Response - Researchers whose proposed use of the data has been approved by an independent review committee identified for this purpose.
- For what types of analyses will this data be available?
Response - For individual participant data meta-analysis.
- By what mechanism will data be made available?
Response - Proposals should be directed to [harshinimanohar1990@gmail.com].
- For how long will this data be available start date provided 21-12-2026 and end date provided 21-12-2031?
Response - Beginning 3 months and ending 5 years following article publication.
- Any URL or additional information regarding plan/policy for sharing IPD?
Additional Information - NIL
|
|
Brief Summary
|
The current study is to be carried out in the National Institute of Mental Health And Neurosciences, Bengaluru. Children and Adolescents with primary diagnosis of OCD and previous failed trial of SSRI/CBT will be recruited for trial of dTMS as an add-on therapy in addition to treatment as usual. It is a single-arm open label trial. Each individual will be screened for inclusion/exclusion criteria, Screening standard questionnaire for TMS safety and comorbidities using DIAMOND-KID. Informed consent from parents and assent from children/adolescents will be taken. 20 sessions of high-frequency deep TMS will be given with one session each day. TMSens_Q, a tool to track adverse effects of TMS will be used to monitor participants and participation will be discontinued in case of any serious adverse effect. OCD severity will be measured using CY-BOCS; Anxiety/depression using RCADS and overall clinical condition using CGI and CGAS scales. Clinical scales will be applied at T1 (Pre-intervention), T2(post-intervention), T3(1 month post-intervention) and T4(3months post-intervention). Linear mixed model will be used to assess the effect of the intervention accounting for within-subject correlations with time as a fixed factor. |